Quotient Sciences has been recognized as a multi-category winner of Clinical Leader/Life Science Leader’s 2024 CRO Leadership Awards.
For the 2024 CRO Leadership Awards, Clinical Leader/Life Science Leader and ISR Reports determined award recipients from a pool of 42 contract research organizations that were assessed on more than 20 different performance metrics in ISR’s annual CRO Quality Benchmarking survey. Winners are judged by customers as either exceeding expectations or as top performers across different categories. To ensure accurate representation, customers can only evaluate CROs they have worked with in the past 18 months.
CROs can win in up to three groups of outsourcing respondents including Big Pharma, Small Pharma, and Overall (combined Big and Small Pharma). This year, Quotient Sciences is the recipient of CRO Leadership Award recognition in Quality and Reliability (Small Pharma).
Quotient Sciences was recognized as a winner of the 2023 CDMO Leadership Awards and in the CRO Leadership Awards in 2020, 2021, and 2022.
See all winners presented by Outsourced Pharma and Life Science Leader